drugset / Trial / NCT00067158

Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1

NCT00067158

Phase 3 Completed 585 enrolled New York University
Treatment

Summary

The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.

Timeline

Start
2003-04
Primary completion
2004-07
Completion
2004-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown Other

Indications